Showing results (1551-1560 of 1,728) with videos related to
Sort By:
Pageof 173
Plos One|September 9, 2016
Extremes of Interferon-Stimulated Gene Expression Associate with Worse Outcomes in the Acute Respiratory Distress SyndromeJerry A Nick, Silvia M Caceres, Jennifer E Kret, et al.Environmental Pollution (Barking, Essex : 1987)|December 15, 2021
Chronic exposure to polluted urban air aggravates myocardial infarction by impaired cardiac mitochondrial function and dynamicsTimoteo Marchini, Natalia Magnani, Mariana Garces, et al.The New England Journal of Medicine|September 22, 1977
Inefficacy of immediate node dissection in stage 1 melanoma of the limbsU Veronesi, J Adamus, D C Bandiera, et al.Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|February 28, 2023
Radiological aspects of lymphomas and leukaemias affecting the jaws: A systematic reviewNathalia Rodrigues Gomes, Lucas Ambrósio Lima, Ana Luísa Morais-Perdigão, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 9, 2025
Genomic and epidemiologic investigation of Mycobacterium abscessus isolates in a cystic fibrosis center to determine potential routes of transmissionJane E Gross, Jason Fullmer, Gregory McCleland, et al.BMJ Open|June 17, 2024
Standardised protocol for a prospective international multicentre clinical-based evaluation of point-of-care tests for the screening of genital and extragenital chlamydial and gonococcal infections in men who have sex with men and for the screening of genital chlamydial, gonococcal and <i>Trichomonas vaginalis</i> infections in at risk womenMaddalena Cordioli, Lorenzo Gios, Massimo Mirandola, et al.Antioxidants & Redox Signaling|August 8, 2013
HNO enhances SERCA2a activity and cardiomyocyte function by promoting redox-dependent phospholamban oligomerizationVidhya Sivakumaran, Brian A Stanley, Carlo G Tocchetti, et al.The Lancet. Oncology|March 6, 2023
Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trialBradley J Monk, Krishnansu S Tewari, Coraline Dubot, et al.The New England Journal of Medicine|September 17, 2021
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical CancerNicoletta Colombo, Coraline Dubot, Domenica Lorusso, et al.Thorax|June 21, 2013
Blood mRNA biomarkers for detection of treatment response in acute pulmonary exacerbations of cystic fibrosisJ A Nick, L A Sanders, B Ickes, et al.Pageof 173